Summer is in full swing, and we have research updates to share plus great ways to get involved in making a difference for the pancreatic cancer community. Our events continue […]
UCLA Joins the Pancreatic Cancer Early Detection (PRECEDE) Consortium to Transform Early Detection and Survival Rates
Dr. Timothy Donahue, Director of the UCLA Agi Hirshberg Center for Pancreatic Diseases and Garry Shandling Chair in Pancreatic Surgery at David Geffen School of Medicine at UCLA, has joined […]
An Overview of the Updates to the NCCN Guidelines for Pancreatic Cancer
The National Comprehensive Cancer Network (NCCN) works to improve cancer care through their vast collection of Guidelines for Patients. The latest version of the Guidelines for Patients: Pancreatic Cancer, sponsored […]
The 2022 UCLA Activity Summary Report
The UCLA Agi Hirshberg Center for Pancreatic Diseases continues to be one of the nation’s leading institutions for pancreatic cancer research, diagnosis, and treatment thanks to funding from the Hirshberg […]
Exciting Changes to the Hirshberg Center for Pancreatic Diseases
We are seeing the seeds we planted 25 years ago with the creation of the Foundation come to full bloom. A pillar of our Foundation mission was “to create premier […]
New insights into pancreatic cancer drug resistance and metastasis
Ethan V. Abel, PhD, a 2021 Seed Grant recipient at Roswell Park Comprehensive Cancer Center, has provided an update on his research in deciphering the role of the HNF1A-SKP2 axis […]